RHÖN-KLINIKUM Aktiengesellschaft/€RHK
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM AG is a German healthcare provider operating five hospital sites: Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen, Universitätsklinikum Marburg (UKGM), and Zentralklinik Bad Berka. The company offers inpatient and outpatient medical services, treating approximately 913,000 patients annually. Headquartered in Bad Neustadt a. d. Saale, Germany, RHÖN-KLINIKUM AG employs over 18,700 individuals. In 2020, Asklepios Kliniken GmbH & Co. KGaA acquired a majority stake in RHÖN-KLINIKUM AG, leading to a strategic partnership while maintaining RHÖN-KLINIKUM AG's independence within the Asklepios group. The company focuses on cross-sector healthcare delivery, digital transformation, and sustainability initiatives, including plans to achieve CO₂-neutrality in Scope 1 and Scope 2 emissions by 2040.
Ticker
€RHK
Sector
Primary listing
XETRA
Employees
19,184
Headquarters
Website
RHK Metrics
BasicAdvanced
€843m
21.14
€0.59
-
€0.20
1.59%
Price and volume
Market cap
€843m
52-week high
€13.40
52-week low
€11.20
Dividend rate
€0.20
Financial strength
Current ratio
2.574
Quick ratio
1.193
Long term debt to equity
8.659
Total debt to equity
8.767
Interest coverage (TTM)
16.86%
Profitability
EBITDA (TTM)
107.815
Gross margin (TTM)
10.43%
Net profit margin (TTM)
2.00%
Operating margin (TTM)
2.59%
Effective tax rate (TTM)
19.12%
Revenue per employee (TTM)
€100,000
Management effectiveness
Return on assets (TTM)
1.74%
Return on equity (TTM)
3.12%
Valuation
Price to earnings (TTM)
21.136
Price to revenue (TTM)
0.423
Price to book
0.63
Price to tangible book (TTM)
0.73
Dividend yield (TTM)
1.59%
Forward dividend yield
1.59%
Growth
Revenue change (TTM)
5.87%
Earnings per share change (TTM)
-0.83%
3-year revenue growth (CAGR)
5.82%
10-year revenue growth (CAGR)
4.82%
3-year earnings per share growth (CAGR)
9.53%
10-year earnings per share growth (CAGR)
-8.65%
3-year dividend per share growth (CAGR)
10.06%
10-year dividend per share growth (CAGR)
-12.94%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs